– Financial reporting – Consolidated statement of changes in equity
Consolidated statement of changes in equity
January 1 – June 30
|
|
|
|
|
Attributable to shareholders of Sulzer Ltd |
|
|
|
|
||||||||||
|
millions of CHF |
|
Notes |
|
Share capital |
|
Retained earnings |
|
Treasury shares |
|
Cash flow hedge reserve |
|
Currency translation adjustment |
|
Total |
|
Non-controlling interests |
|
Total equity |
|
Equity as of January 1, 2021 |
|
|
|
0.3 |
|
2’083.8 |
|
–38.3 |
|
5.9 |
|
–647.4 |
|
1’404.3 |
|
12.9 |
|
1’417.2 |
|
Comprehensive income for the period: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
|
|
|
85.7 |
|
|
|
|
|
|
|
85.7 |
|
0.7 |
|
86.3 |
|
- Cash flow hedges, net of tax |
|
|
|
– |
|
– |
|
– |
|
–4.1 |
|
– |
|
–4.1 |
|
– |
|
–4.1 |
|
- Remeasurements of defined benefit plans, net of tax |
|
|
|
– |
|
55.6 |
|
– |
|
– |
|
– |
|
55.6 |
|
– |
|
55.6 |
|
- Currency translation differences |
|
|
|
– |
|
– |
|
– |
|
– |
|
74.7 |
|
74.7 |
|
0.4 |
|
75.1 |
|
Other comprehensive income |
|
|
|
– |
|
55.6 |
|
– |
|
–4.1 |
|
74.7 |
|
126.2 |
|
0.4 |
|
126.6 |
|
Total comprehensive income for the period |
|
|
|
– |
|
141.3 |
|
– |
|
–4.1 |
|
74.7 |
|
211.9 |
|
1.1 |
|
212.9 |
|
Transactions with owners of the company: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition of non-controlling interests without a change of control |
|
|
|
– |
|
–10.6 |
|
– |
|
– |
|
–1.4 |
|
–11.9 |
|
–5.4 |
|
–17.3 |
|
Transaction costs |
|
11 |
|
– |
|
–0.7 |
|
– |
|
– |
|
– |
|
–0.7 |
|
– |
|
–0.7 |
|
Allocation of treasury shares to share plan participants |
|
|
|
– |
|
–8.5 |
|
8.5 |
|
– |
|
– |
|
– |
|
– |
|
– |
|
Purchase of treasury shares |
|
|
|
– |
|
– |
|
–14.5 |
|
– |
|
– |
|
–14.5 |
|
– |
|
–14.5 |
|
Share-based payments |
|
|
|
– |
|
9.2 |
|
– |
|
– |
|
– |
|
9.2 |
|
– |
|
9.2 |
|
Dividends |
|
11 |
|
– |
|
–135.4 |
|
– |
|
– |
|
– |
|
–135.4 |
|
–2.1 |
|
–137.5 |
|
Equity as of June 30, 2021 |
|
|
|
0.3 |
|
2’079.1 |
|
–44.3 |
|
1.7 |
|
–574.1 |
|
1’462.8 |
|
6.4 |
|
1’469.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity as of January 1, 2022 |
|
|
|
0.3 |
|
1’967.7 |
|
–51.0 |
|
3.3 |
|
–646.5 |
|
1’273.8 |
|
5.5 |
|
1’279.3 |
|
Comprehensive income for the period: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
|
|
|
–48.3 |
|
|
|
|
|
|
|
–48.3 |
|
–0.5 |
|
–48.8 |
|
- Cash flow hedges, net of tax |
|
|
|
– |
|
– |
|
– |
|
–2.8 |
|
– |
|
–2.8 |
|
– |
|
–2.8 |
|
- Remeasurements of defined benefit plans, net of tax |
|
2 |
|
– |
|
–107.0 |
|
– |
|
– |
|
– |
|
–107.0 |
|
– |
|
–107.0 |
|
- Equity investments at FVOCI – net change in fair value |
|
|
|
– |
|
–12.0 |
|
– |
|
– |
|
– |
|
–12.0 |
|
– |
|
–12.0 |
|
- Currency translation differences |
|
|
|
– |
|
– |
|
– |
|
– |
|
13.5 |
|
13.5 |
|
0.2 |
|
13.7 |
|
Other comprehensive income |
|
|
|
– |
|
–119.0 |
|
– |
|
–2.8 |
|
13.5 |
|
–108.3 |
|
0.2 |
|
–108.1 |
|
Total comprehensive income for the period |
|
|
|
– |
|
–167.3 |
|
– |
|
–2.8 |
|
13.5 |
|
–156.6 |
|
–0.3 |
|
–156.9 |
|
Transactions with owners of the company: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contribution from medmix |
|
11 |
|
– |
|
0.4 |
|
– |
|
– |
|
– |
|
0.4 |
|
|
|
0.4 |
|
Transaction costs |
|
11 |
|
– |
|
–0.7 |
|
– |
|
– |
|
– |
|
–0.7 |
|
|
|
–0.7 |
|
Allocation of treasury shares to share plan participants |
|
|
|
– |
|
–27.0 |
|
27.0 |
|
– |
|
– |
|
– |
|
|
|
– |
|
Purchase of treasury shares |
|
|
|
– |
|
– |
|
–10.8 |
|
– |
|
– |
|
–10.8 |
|
|
|
–10.8 |
|
Share-based payments |
|
|
|
– |
|
7.2 |
|
– |
|
– |
|
– |
|
7.2 |
|
|
|
7.2 |
|
Dividends |
|
11 |
|
– |
|
–118.7 |
|
– |
|
– |
|
– |
|
–118.7 |
|
–1.1 |
|
–119.8 |
|
Equity as of June 30, 2022 |
|
|
|
0.3 |
|
1’661.8 |
|
–34.9 |
|
0.6 |
|
–633.1 |
|
994.7 |
|
4.1 |
|
998.8 |
Due to rounding, numbers presented may not add up to the totals provided.